Novo Nordisk
Manufacturing · Denmark · 69,260 Employees
View Company Info for Free
About
Headquarters
1 Novo Allé, Bagsvaerd, Capital Region, 2880, D...Phone Number
+45 44448888Website
novonordisk.comRevenue
$38.7 BillionStock Symbol
NONOFIndustry
Most Recent Scoops
Who is Novo Nordisk
Novo Nordisk is a leading global healthcare company, founded in 1989 and headquartered in Denmark. Our purpose is to drive change to defeat diabete s and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease.Read more
Popular SearchesNovo Nordisk A/SNovo Nordisk IncNovo NordiskNovo Nordisk LtdNovo Nordisk Canada IncSIC Code 28,283NAICS Code 32,325Ticker OTC:NONOFShow moreNovo Nordisk Org Chart
Is Novo Nordisk your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Novo Nordisk launches new products
Check if Novo Nordisk has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Novo Nordisk recently announced quarterly report
Click to see if Novo Nordisk had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Novo Nordisk has new funding data
Congratulate Masked Content for being promoted to Masked Content at Novo Nordisk
Novo Nordisk, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Novo Nordisk is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Similar Companies to Novo Nordisk
Analyze insights from companies similar to Novo Nordisk and make strategic comparisons based on performance, financial data, growth and unique benchmarks.
- Eli Lilly43,000$35.9B
- Bristol-Myers Squibb34,100$45.5B
- Baxter International60,000$15B
- Takeda47,347$26.9B
- Pfizer88,000$54.9B
- GSK70,212$40B
- AbbVie50,000$54.4B
- Amgen26,700$29.5B
More similar companies
Novo Nordisk Email Formats
Novo Nordisk uses at least 5 email formats with last + first initials (ex. SmithJ@novonordisk.com) being used 26.7% of the time
Novo Nordisk Email Formats | Percentage | |
---|---|---|
last + first initials | SmithJ@novonordisk.com | 26.7% |
first initials + last | JSmith@novonordisk.com | 21.8% |
last | Smith@novonordisk.com | 16.8% |
first initials + last initials | JSmi@novonordisk.com | 7.9% |
first initials + middle initials + last initials | JLS@novonordisk.com | 5% |
Get Verified Emails
Novo Nordisk Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Novo Nordisk Tech Stack
A closer look at the technologies used by Novo Nordisk
Most Recent Scoops
Novo Nordisk News & Media
Novo Nordisk A/S – Share repurchase programme
Bagsværd, Denmark, 30 September 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month periodNovo Nordisk Just Committed More Than $1.1 Billion to Make the Next Ozempic, but Is the Stock a Buy?
The thrust of the company's long-term strategy is becoming clearer.Senate panel questions Novo Nordisk CEO over decision to discontinue this popular insulin
Novo Nordisk CEO explains decision to discontinue the long-acting insulin Levemir. He blamed pharmacy managers and health insurers.Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead
Even the mighty Novo Nordisk can't hold a candle to its peer in this area.
Frequently Asked Questions Regarding Novo Nordisk
Novo Nordisk is a leading global healthcare company, founded in 1989 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and... Read More